• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4612195)   Today's Articles (3391)   Subscriber (49382)
For: Ercaliskan A, Eskazan AE. Bosutinib - an effective and safe treatment option in the management of chronic myeloid leukemia. Future Oncol 2020;16:4425-4428. [PMID: 31920102 DOI: 10.2217/fon-2020-0006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]  Open
Number Cited by Other Article(s)
1
Shi M, Wang L, Liu K, Chen Y, Hu M, Yang L, He J, Chen L, Xu D. Molecular Dynamics Simulations of the Conformational Plasticity in the Active Pocket of Salt-Inducible Kinase 2 (SIK2) Multi-State Binding with Bosutinib. Comput Struct Biotechnol J 2022;20:2574-2586. [PMID: 35685353 PMCID: PMC9160496 DOI: 10.1016/j.csbj.2022.05.039] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2022] [Revised: 05/18/2022] [Accepted: 05/19/2022] [Indexed: 11/06/2022]  Open
2
Yüzbaşıoğlu MB, Eşkazan AE. Bosutinib - related pleural effusion in patients with chronic myeloid leukemia. Expert Opin Drug Saf 2021;20:379-381. [PMID: 33339467 DOI: 10.1080/14740338.2021.1867103] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
3
Yilmaz U, Eskazan AE. Moving on from 2013 to 2020 European LeukemiaNet recommendations for treating chronic myeloid leukemia: what has changed over the 7 years? Expert Rev Hematol 2020;13:1035-1038. [PMID: 32814447 DOI: 10.1080/17474086.2020.1813564] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA